A case of subacute cutaneous lupus erythematosus as a result of ranibizumab (Lucentis) treatment.
Loading...
Date
2013-12
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Cutaneous lupus erythematosus is a previously undiagnosed side‑effect of ranibizumab. Here, we present
a case of an 82‑year‑old female Caucasian patient with wet age‑related macular degeneration. Following
a single intraocular injection of Lucentis (ranibizumab), she developed a subacute cutaneous lupus
erythematosus which, with treatment, took nearly 12 months to resolve. This shows that cutaneous lupus
erythematosus is a potential side‑effect of many medications, including ranibizumab, as in our case and,
in an aging population where polypharmacy is a growing reality, clinicians should be aware of how to
diagnose and best manage such cases.
Description
Keywords
Drug reaction, drug‑induced, ranibizumab, subacute cutaneous lupus erythematosus
Citation
Andric Marko, Dixit Shreya, Robaei Dana, Watchorn Rosemary, Verma Nitin. A case of subacute cutaneous lupus erythematosus as a result of ranibizumab (Lucentis) treatment. Indian Journal of Ophthalmology. 2013 Dec ; 61 (12): 752-754.